![]() |
Toll Free 877-238-1437
|
Over the past two decades, breast conserving treatment, consisting of lumpectomy and external beam radiotherapy, has become a standard treatment option for patients with early stage cancer. It has been demonstrated to offer similar local control and survival results compared with mastectomy, while providing acceptable cosmetic outcome, and less emotional trauma. However, the primary disadvantages are 6 to 7 weeks of external beam treatment and potential side effects to the adjacent organs such as the underlying lungs and scatter radiation dose to the opposite breast. | ![]() |
![]() |
The protruding ends of the plastic catheters are connected via longer, transfer tubes to the treatment unit, called the afterloader, that contains the tiny radioactive source. The tiny (1mmx3mm) source is welded to the tip of a flexible stainless steel cable that travels in and out of the treatment catheters. The source steps through each of the catheters, stopping every 5mm to deliver the required radiation dose. After the treatment is delivered, the source retracts into the afterloader, the treatment catheters are disconnected from the transfer tubes, the nurses cover the implant with dressings and the patient goes home. The time the source spends in the catheters is about 10 minutes. |
Fig 2: 3D computer simulation showing radiation dose cloud. | ||
![]() |
||
![]() |
![]() |
![]() |
||||
Fig 3: 2 months after treatment. | Fig 4: 10 months after treatment. | Fig 5: 3 years after treatment, achieve excellent cosmetic result. | ||||
![]() |
American Society for Therapeutic Radiology And Oncology Chair - Health Policy and Economics Practice Management Subcommittee, Chair - Regulatory Subcommittee, Member - Health Policy and Economic Committee, Member - Health Policy and Economics Code Development and Valuation Subcommittee, Member - Code Utilization and Application Subcommittee. |
![]() |
|
![]() |
American College of Radiation Oncology President - 2005 to 2006 |